C section News and Research

RSS

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

Scientists and engineers from around the world will gather on the shores of Lake Ontario in Rochester, N.Y. next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.

21 Oct 2010

FDA asks manufacturers to add new warnings to labeling of prostate cancer drugs

The U.S. Food and Drug Administration today asked manufacturers to add new warnings to labeling of gonadotropin-releasing hormone (GnRH) agonists, a class of drugs primarily used to treat men with prostate cancer.

21 Oct 2010

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

20/20 GeneSystems, Inc. announced today at the AdvaMed MedTech Conference in Washington, D.C. that the company has been awarded nearly $3 million in grants from the National Cancer Institute's (NCI) Small Business Innovative Research (SBIR) Program to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

20 Oct 2010

BioMarin announces BMN-111 program for treatment of achondroplasia

BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.

19 Oct 2010

SheKnows City Guide helps women to get expert advice on health

SheKnows one of the fastest growing online content and community global destinations for women, just launched a new city-specific resource titled SheKnows City Guide.

19 Oct 2010

TearLab announces publication of CPT code for Osmolarity test

TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.

19 Oct 2010

Tips to help keep teeth and gums healthy

Good nutrition and healthy eating habits are essential to maintaining optimal oral and overall health. With Halloween just around the corner, the Pennsylvania Dental Association (PDA) encourages parents to be mindful of the amount of candy their children are consuming, and to use this holiday as an opportunity to remind them about the importance of taking care of their teeth and gums.

15 Oct 2010

CoreLab offers state-of-the-art imaging solutions for DXA imaging sciences

CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA).

15 Oct 2010

Experts use multi-disciplinary approach to provide innovative care for children

Liver tumors affect more than 300 children in the United States each year and management of these children requires coordinated comprehensive care from experts in many disciplines. To answer this problem, Texas Children's Hospital and Baylor College of Medicine announced today the formation of a new Liver Tumor Center that brings together renowned specialists in all aspects of liver cancer who will utilize a multi-disciplinary approach to provide the most comprehensive and innovative care for children afflicted with these diseases.

15 Oct 2010

Scientists identify protein in urine can indicate prostate cancer risk

Cancer research UK scientists have shown that a protein in urine could be a powerful indicator of prostate cancer risk, according to a study published in PLoS ONE.

14 Oct 2010

$FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates$

FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates

The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk. Bisphosphonates inhibit the loss of bone mass in people with osteoporosis.

14 Oct 2010

Mayo Clinic researcher named by National Academy of Sciences to Institute of Medicine

Mayo Clinic radiologist and researcher Richard Ehman, M.D., has been named by the National Academy of Sciences to the Institute of Medicine. Selection to the Institute (one of the four Academies, based in Washington, D.C.) is one of the highest honors in medicine in the United States.

13 Oct 2010

SNM and SPR approve new North American Guidelines for Radiopharmaceutical Doses for Children

The Society of Nuclear Medicine (SNM) and the Society for Pediatric Radiology's Board of Directors recently approved new North American Guidelines for Radiopharmaceutical Doses for Children. These societies have expanded their pediatric radiation protection initiative by standardizing doses (based on body weight) for 11 nuclear medicine procedures commonly performed in children. The Alliance for Radiation Safety in Pediatric Imaging has collaborated in this effort, and will support efforts to promote the new, lower radiopharmaceutical doses.

13 Oct 2010

Global study finds new set of genes associated with body fat distribution and obesity

Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.

12 Oct 2010

$Pazopanib shows promise in phase-2 trial for relapsed/refractory urothelial cancer$

Pazopanib shows promise in phase-2 trial for relapsed/refractory urothelial cancer

An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.

11 Oct 2010

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.

11 Oct 2010

Administration's waivers of health law raise questions about 'mini-med' plans

The White House on Thursday defended granting waivers to some employers from a key provision of the new health care law, saying it was the best way to keep people insured until the law fully takes effect.

11 Oct 2010

N.Y. officials seek to ban purchase of sugary drinks with food stamps

"New Yorkers on food stamps would not be allowed to spend them on sugar-sweetened drinks under an obesity-fighting proposal being floated by Mayor Michael Bloomberg and Gov. David Paterson. Bloomberg and Paterson planned to announce Thursday that they are seeking permission from the U.S. Department of Agriculture, which administers the nation's food stamp program, to add sugary drinks to the list of prohibited goods for city residents receiving assistance. If approved, it would be the first time an item would be banned from the federal program based solely on nutritional value" (Kugler Frazier, 10/7).

8 Oct 2010

Genzyme board of directors vote to reject tender offer from Sanofi-Aventis

Genzyme Corp. announced today that its board of directors has voted unanimously to reject the unsolicited $69.00 per share tender offer from Sanofi-Aventis, and the board recommends that Genzyme shareholders not tender their shares to Sanofi-Aventis pursuant to the offer.

8 Oct 2010

Role of TGF-ß in cancer diseases

During this year's BIOTECHNICA exhibition, the international biotech news magazine „GEN - Genetic Engineering & Biotechnology News yesterday on 5 October 2010, held an information event with subsequent panel discussion featuring the topic TGF-ß an important target in cancer diseases.

7 Oct 2010

C section News and Research

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

FDA asks manufacturers to add new warnings to labeling of prostate cancer drugs

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

BioMarin announces BMN-111 program for treatment of achondroplasia

SheKnows City Guide helps women to get expert advice on health

TearLab announces publication of CPT code for Osmolarity test

Tips to help keep teeth and gums healthy

CoreLab offers state-of-the-art imaging solutions for DXA imaging sciences

Experts use multi-disciplinary approach to provide innovative care for children

Scientists identify protein in urine can indicate prostate cancer risk

FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates

Mayo Clinic researcher named by National Academy of Sciences to Institute of Medicine

SNM and SPR approve new North American Guidelines for Radiopharmaceutical Doses for Children

Global study finds new set of genes associated with body fat distribution and obesity

Pazopanib shows promise in phase-2 trial for relapsed/refractory urothelial cancer

Afinitor-Sandostatin LAR Depot combination extends median PFS in patients with advanced carcinoid tumors

Administration's waivers of health law raise questions about 'mini-med' plans

N.Y. officials seek to ban purchase of sugary drinks with food stamps

Genzyme board of directors vote to reject tender offer from Sanofi-Aventis

Role of TGF-ß in cancer diseases

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News